Investing Profile
Stefan Pflanz
InvestorVC
Executive Director Boehringer-Ingelheim Venture Fund USA
boehringer-ingelheim-venture....San Francisco Bay Area
Your Intro Paths to Stefan Pflanz
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Current Investing Position
Boehringer Ingelheim Venture Fund Investor
Investment Range
$3.3M - $17.0M
Sweet Spot
$8.5M
Stefan Pflanz is on these Sector & Stage Rankings
Stefan Pflanz's Experience
Executive Director Boehringer-Ingelheim Venture Fund USA Boehringer Ingelheim2020 - Present
Director Cancer Immunology and Immune Modulation Boehringer Ingelheim Pharmaceuticals2016 - 2020
Senior Research Scientist Gilead Sciences2011 - 2016
Visiting Scientist in Department of Dermatology UCSF Medical Center2010 - 2011
Head of Cytokine Biology Schering-Plough Biopharma2006 - 2010
Head of Target Research Micromet Inc2004 - 2006
Group Leader SCA Therapeutics Micromet Inc2003 - 2004
Postdoctoral Fellow DNAX Research Institute (USA)2000 - 2002
PhD student RWTH Aachen1996 - 1999
Stefan Pflanz's Education
University of Aachen PhD Immunology, Molecular Biology, Biochemistry